Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers November 21, 2017
Pharmacy Choice - Pharmaceutical News - Nutra Pharma and Nyloxin Featured on NBC News-Miami - November 21, 2017

Pharmacy News Article

 2/15/17 - Nutra Pharma and Nyloxin Featured on NBC News-Miami

Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter (OTC) pain management market, announced today that the Company and their products were featured in an interview aired last night on Miami's NBC News affiliate (

NBC News has been featuring the use of natural products for the treatment of a variety of ailments, commented Rik J Deitsch, CEO of Nutra Pharma. For the most part, these reports have discussed the use of marijuana. Nutra Pharma's Nyloxin has been shown to be just as potent as opiate pain relievers without the side effects caused by the use of opiates or marijuana, he continued. The report focusses on Nyloxin and Pet Pain-Away. These are clinically proven, legal and all-natural products that are available today to deal with pain and inflammation in people and their pets, he concluded.

The interview was conducted by Jamie Guirola with filming at Nutra Pharma's laboratory facility and the reptile farm that houses their cobras for venom production. Jamie, through his interviews, learned about cobra venom and its use as a potent pain-reliever (analgesic) and anti-inflammatory agent.

Nutra Pharma will announce further strategic business segment actions over the coming weeks. The Company expects to address Nyloxin chronic pain solutions for the Sports-Athletic market as well as for Aging Individuals and Baby Boomers. Nutra Pharma is also addressing chronic pain in pets, especially dogs and cats, with Pet Pain-Away?.

About Nutra Pharma Corp.
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets drug products for sale for the treatment of pain under the brand Nyloxin and Pet Pain-Away?. For additional information about Nutra Pharma, visit: or

SEC Disclaimer
This press release contains forward-looking statements. The words or phrases would be, will allow, intends to, will likely result, are expected to, will continue, is anticipated, estimate, project, or similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those projected in Nutra Pharma's (the Company) business plan. The news piece on NBC News should not be construed as an indication in any way whatsoever of the future value of the Company's common stock or its financial value. The Company's filings may be accessed at the SEC's Edgar system at Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.

Nutra Pharma Corp.
Nina Goldstein

The post Nutra Pharma and Nyloxin Featured on NBC News-Miami appeared first on Investing News Network.

© 2017 Investing News Network. All Rights Reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Nov 21: Standards of Practice for Filling Controlled Substance Prescriptions in Florida
Last Chance
Nov 22: Medical Marijuana: Examining the Science, Not the Politics
Nov 27: Drug Diversion and the Law: Updates and Considerations
Nov 28: An Integrative Approach to Managing Arthritis
Nov 29: Influenza 2017-2018: An Update on Prevention and Treatment
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement